Prevalence of elevated serum transferrin saturation in adults in the United States

Annals of Internal Medicine

Volumn 129, Issue 11, 1998, Pages 940-945

  Looker, Anne C ^a,b   Johnson, Clifford L ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; TRANSFERRIN;

ADULT; ARTICLE; FEMALE; FERRITIN BLOOD LEVEL; HEMOCHROMATOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SCREENING; SEX DIFFERENCE; UNITED STATES;

EID: 0032401728     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-11_part_2-199812011-00004     Document Type: Article

References (38)

1. Bradley LA, Haddow JE, Palomaki GE. Population screening for haemochromatosis: a unifying analysis of published intervention trials. J Med Screen. 1996;3:178-84.
2. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta. 1996;245:139-200.
3. Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med. 1993;328:1616-20.
4. Phatak PD, Guzman G, Woll JE, Robeson A, Phelps CE. Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med. 1994; 154:769-76.
5. Buffone GJ, Beck JR. Cost-effectiveness analysis for evaluation of screening programs: hereditary hemochromatosis. Clin Chem. 1994;40:1631-6.
6. Balan V, Baldus W, Fairbanks V, Michels V, Burritt M, Klee G. Screening for hemochromatosis: a cost-effectiveness study based on 12,258 patients. Gastroenterology. 1994;107:453-9.
7. Leggett BA, Halliday JW, Brown NN, Bryant S, Powell LW. Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol. 1990; 74:525-30.
8. Jonsson JJ, Johannesson GM, Sigfusson N, Magnusson B, Thjodleifsson B, Magnusson S. Prevalence of iron deficiency and iron overload in the adult Icelandic population. J Clin Epidemiol. 1991;44:1289-97.
9. Baer DM, Simons JL, Staples RL, Rumore GJ, Morton CJ. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. Am J Med. 1995;98:464-8.
10. Karlsson M, Ikkala E, Reunanen A, Takkunen H, Vuori E, Makinen J. Prevalence of hemochromatosis in Finland. Acta Med Scand. 1988;224:385-90.
11. Elliott R, Lin BP, Dent OF, Tait A, Smith CI. Prevalence of hemochromatosis in a random sample of asymptomatic men. Aust N Z J Med. 1986;16: 491-5.
12. Lindmark B, Eriksson S. Regional differences in the idiopathic hemochromatosis gene frequency in Sweden. Acta Med Scand. 1985;218:299-304.
13. Olsson KS, Eriksson K, Ritter B, Heedman PA. Screening for iron overload using transferrin saturation. Acta Med Scand. 1984;215:105-12.
14. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med. 1988;318:1355-62.
15. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-94. Hyattsville, MD: U.S. Dept of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Health Statistics; 1994: DHHS publication no. (PHS) 94-1308. (Vital and Health Statistics; series 1; no. 32).
16. Gunter EW, Lewis BL, Koncikowski SM. Laboratory methods used for the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 [CD-ROM]. Hyattsville, MD: Centers for Disease Control and Prevention; 1996. Available from National Technical Information Service, Springfield, Virginia.
17. Looker AC, Gunter EW, Johnson CL. Methods to assess iron status in various NHANES surveys. Nutr Rev. 1995;53:246-54.
18. Custer EM, Finch CA, Sobel RE, Zettner A. Population norms for serum ferritin. J Lab Clin Med. 1995;126:88-94.
19. Iron overload disorders among Hispanics - San Diego, California, 1995. MMWR Morb Mortal Wkly Rep. 1996;45:991-3.
20. Mohadjer L, Montaquila J, Waksberg J, Bell B, James P, Flores-Cervantes I, et al. National Health and Nutrition Examination Survey III. Weighting and Estimation Methodology. Rockville, MD: WESTAT, Inc.; 1996.
21. Shah, BV, Barnwell BG, Hunt PN, LaVange LM. SUDAAN User's Manual. Release 5.50. Research Triangle Park, NC: Research Triangle Institute; 1991.
22. Methodological Subcommittee on the HNIS/NCHS Analytic Working Group. Joint policy on variance estimation and statistical reporting standards on NHANES III and CSFII reports: HNIS/NCHS Analytic Working Group recommendations. In: Analytic and Reporting Guidelines, Third National Health and Nutrition Examination Survey (NHANES III, 1988-94) Reference Manuals and Reports [CD-ROM]. Hyattsville, MD: Centers for Disease Control and Prevention; 1996. Available from National Technical Information Service, Springfield, Virginia.
23. Ezzati TM, Massey JT, Waksberg J, Chu A, Maurer KR. Sample Design: Third National Health and Nutrition Examination Survey. Hyattsville, MD: US Dept of Health and Human Services, Public Health Service, Centers for Disease Control, National Center for Health Statistics; 1992: DHHS publication no. 92-1387. (Vital and Health Statistics; series 2; no 113).
24. Hamilton LD, Gubler CJ, Cartwright GE, Wintrobe MM. Diurnal variation in the plasma iron level of man. Proc Soc Exp Biol Med. 1950;75:65-8.
25. Statland BE, Winkel P, Bokelund H. Variation of serum iron concentration in young healthy men: within-day and day-to-day changes. Clin Biochem. 1976;9:26-9.
26. Crosby WH, O'Neil-Cutting MA. A small-dose iron tolerance test as an indicator of mild iron deficiency. JAMA. 1984;251:1986-7.
27. Yip R, Dallman PR. The roles of inflammation and iron deficiency as causes of anemia. Am J Clin Nutr. 1988;48:1295-300.
28. Cogswell ME, McDonnell SM, Khoury MJ, Franks AL, Burke W, Brittenham G. Iron overload, public health, and genetics: evaluating the evidence for hemochromatosis screening. Ann Intern Med. 1998;129:971-9.
29. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet. 1997;34: 275-8.
30. Monaghan KG, Rybicki BA, Shurafa M, Feldman GL. Mutation analysis of the HFE gene associated with hereditary hemochromatosis in African Americans. Am J Hematol. 1998;58:213-7.
31. Barton JC, Edwards CQ, Bertoli LF, Shroyer TW, Hudson SL. Iron overload in African Americans. Am J Med. 1995;99:616-23.
32. Wurapa RK, Gordeuk VR, Brittenham GM, Khiyami A, Schechter GP, Edwards CQ. Primary iron overload in African Americans. Am J Med. 1996; 101:9-18.
33. Edwards CQ, Griffen LM, Kaplan J, Kushner JP. Twenty-four hour variation of transferrin saturation in treated and untreated haemochromatosis homozygotes. J Intern Med. 1989;226:373-9.
34. Lammi-Keefe CJ, Lickteig ES, Ahluwalia N, Haley NR. Day-to-day variation in iron status indexes is similar for most measures in elderly women with and without rheumatoid arthritis. J Am Diet Assoc. 1996;96:247-51.
35. Witte DL. Can serum ferritin be effectively interpreted in the presence of the acute-phase response? [Editorial] Clin Chem. 1991;37:484-5.
36. Hulthen L, Lindstedt G, Lundberg PA, Hallberg L. Effect of a mild infection on serum ferritin concentration - clinical and epidemiological implications. Eur J Clin Nutr. 1998;52:376-9.
37. Ezzati T, Khare M. Nonresponse adjustments in a national health survey. In: 1992 Proceedings of the American Statistical Association, Section on Survey Research Methods. Alexandria, VA: American Statistical Assoc; 1992:339-44.
38. Mohadjer L, Bell B, Waksberg J. National Health and Nutrition Examination Survey III. Accounting for Item Nonresponse Bias. Rockville, MD: WESTAT, Inc.; 1996.